Relay Therapeutics, Inc. RLAY Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$276.48M+18.1% | -$337.71M+1.2% | -$341.97M-17.7% | -$290.51M+20.2% | ||
| $3.56M-34.9% | $5.46M+3.7% | $5.27M+27.6% | $4.13M+5.2% | ||
| $62.42M-33.7% | $94.14M+9.4% | $86.03M+53.2% | $56.14M+15.9% | ||
| -$11.44M-211% | $10.27M+529% | -$2.39M-220% | $1.99M+114% | ||
| —— | $786K+103% | -$24.95M-332% | $10.76M-28.3% | ||
| —— | $7.68M— | —— | -$248K— | ||
| -$1.61M-129% | $5.5M— | —— | —— | ||
| -$235.46M+5.5% | -$249.11M+17.1% | -$300.32M-30.9% | -$229.49M-208% | ||
| $411K-79.6% | $2.02M-51.1% | $4.13M-54.5% | $9.06M+161% | ||
| $122.97M-81.1% | $650.63M+68.8% | $385.54M-28.0% | $535.42M-45.4% | ||
| $316.18M-48.3% | $611.56M-5.5% | $647.3M+82.0% | $355.74M-32.9% | ||
| $192.8M— | —— | $257.63M— | —— | ||
| —— | $270.15M+677% | $34.75M-88.0% | $289.91M-25.3% | ||
| —— | -$20.04M— | —— | -$128.33M— | ||
| $4.95M-59.8% | $12.32M+14.4% | $10.76M— | —— | ||
| $3.56M-34.9% | $5.46M+3.7% | $5.27M+27.6% | $4.13M+5.2% | ||
| —— | $101K— | —— | —— | ||
| —— | $7.68M— | —— | -$248K— | ||
| —— | -$1.24M+17.6% | -$1.51M-119% | $8.13M+3,036% | ||
| -$1.61M-129% | $5.5M— | —— | —— | ||
| —— | —— | $1.99M-42.9% | $3.48M-26.6% | ||
| —— | —— | —— | —— | ||
| $6.91M— | —— | —— | $46.63M— | ||
| —— | —— | $410K+158% | $159K— | ||
| —— | $2.51M— | —— | —— | ||
| -$235.87M+6.1% | -$251.13M+17.5% | -$304.44M-27.6% | -$238.55M-206% | ||
| -$235.87M+6.1% | -$251.13M+17.5% | -$304.44M-27.6% | -$238.55M-206% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Relay Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.